CDK 4/6 inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CDK 4/6 inhibitor, covering 2013-12-31 to 2013-12-31. Get the full timeline:
Most recent: Clinical Trial Update: Letrozole and CDK 4/6 Inhibitor for ER Positive, HER2 Negative Breast Cancer in Postmenopausal Women [Phase 2]